Ohio HB276 prohibits certain actions by drug manufacturers and logistics providers regarding reimbursements to 340B covered entities.
Ohio HB276 amends the state's insurance laws to prohibit manufacturers, repackagers, and logistics providers of dangerous drugs from limiting or restricting the acquisition or delivery of 340B drugs to 340B grantees, unless prohibited by federal law. It also prohibits these entities from requiring the submission of claims or utilization data as a condition for drug acquisition or delivery, unless required by federal law. The bill mandates health plan issuers, including pharmacy benefit managers, to provide specified data to covered persons or their representatives upon request.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.